Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent LeasesGoodwillGoodwill & IntangiblesIntangiblesLiabilities and Shareholders EquityNon-Current AssetsNon-Current DebtNon-Current Deferred Tax LiabilityOperating LeasesOther Accumulated ExpensesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)ReceivablesReceivables - NetReceivables - OtherRetained EarningsShareholder's EquityShort term DebtTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current LiabilitiesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Rxo (RXO) Assets (2021 - 2025)

Historic Assets for Rxo (RXO) over the last 5 years, with Q4 2025 value amounting to $3.3 billion.

  • Rxo's Assets fell 401.29% to $3.3 billion in Q4 2025 from the same period last year, while for Dec 2025 it was $3.3 billion, marking a year-over-year decrease of 401.29%. This contributed to the annual value of $3.3 billion for FY2025, which is 401.29% down from last year.
  • Rxo's Assets amounted to $3.3 billion in Q4 2025, which was down 401.29% from $3.2 billion recorded in Q3 2025.
  • In the past 5 years, Rxo's Assets ranged from a high of $3.4 billion in Q4 2024 and a low of $1.8 billion during Q1 2024
  • Moreover, its 5-year median value for Assets was $2.1 billion (2021), whereas its average is $2.5 billion.
  • Its Assets has fluctuated over the past 5 years, first tumbled by 1300.85% in 2023, then skyrocketed by 8706.85% in 2024.
  • Rxo's Assets (Quarter) stood at $2.1 billion in 2021, then dropped by 1.79% to $2.0 billion in 2022, then dropped by 10.14% to $1.8 billion in 2023, then skyrocketed by 87.07% to $3.4 billion in 2024, then decreased by 4.01% to $3.3 billion in 2025.
  • Its last three reported values are $3.3 billion in Q4 2025, $3.2 billion for Q3 2025, and $3.2 billion during Q2 2025.